JJamjoom Pharma: directors' dealings · Saudi Arabia · Tadawul (CMA)
TADAWUL:4015SASA·Tadawul (CMA)Mcap 10.9Bn€Healthcare
Explore the full management transaction log of Jamjoom Pharma, a listed issuer based in Saudi Arabia. Shares are listed on SA SA, under the supervision of Tadawul (CMA). Operating in the Healthcare sector, Jamjoom Pharma has published 1 reports. Market capitalisation: €10.9bn. The latest transaction was filed on 4 July 2023 — Board / executive change. Every trade is free.
Financial data
FY ended December 2024 · cache
Analyst consensus
3 analysts160.00 €Target 164.24 €(+6%)172.00 €
Income statement
Revenue1.32 Bn€
Gross profit820.5 M€62% margin
Net income356.5 M€31.2% margin
Valuation
PER (trailing)24.3x
P/Book6.3x
Beta0.33
Balance sheet & cash
Market cap10.86 Bn€
Total debt2.1 M€
Free Cash Flow206.3 M€
Debt / Equity1%
Profitability & ownership
ROE29.0%
ROA15.2%
% insiders60.9%
% institutions3.1%
Last declaration on 4 July 2023